Journal Article DKFZ-2024-02169

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Malformin C preferentially kills glioblastoma stem-like cells via concerted induction of proteotoxic stress and autophagic flux blockade.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
John Wiley & Sons, Inc. Hoboken, NJ

Molecular oncology 19(3), 785-807 () [10.1002/1878-0261.13756]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Glioblastoma is a highly aggressive brain tumor for which there is no cure. The dire prognosis of this disease is largely attributable to a high level of heterogeneity, including the presence of a subpopulation of tumor-initiating glioblastoma stem-like cells (GSCs), which are refractory to chemo- and radiotherapy. Here, in an unbiased marine-derived fungal extract screen, together with bioguided dereplication based on high-resolution mass spectrometry, we identified malformin C to preferentially induce cell death in patient-derived GSCs and explore the potential of this cyclic peptide as a therapeutic agent for glioblastoma. Malformin C significantly reduced tumor growth in an in vivo xenograft model of glioblastoma. Using transcriptomics and chemoproteomics, we found that malformin C binds to many proteins, leading to their aggregation, and rapidly induces the unfolded protein response, including autophagy, in GSCs. Crucially, chemical inhibition of translation using cycloheximide rescued malformin C-induced cell death in GSCs, demonstrating that the proteotoxic effect of the compound is necessary for its cytotoxicity. At the same time, malformin C appears to accumulate in lysosomes, disrupting autophagic flux, and driving cells to death. Supporting this, malformin C synergizes with chloroquine, an inhibitor of autophagy. Strikingly, we observed that autophagic flux is differentially regulated in GSCs compared with normal astrocytes. The sensitivity of GSCs to malformin C highlights the relevance of proteostasis and autophagy as a therapeutic vulnerability in glioblastoma.

Keyword(s): autophagy ; cancer ; compound screen ; glioblastoma ; proteostasis ; stem cells ; unfolded protein response

Classification:

Note: #EA:B067#LA:B067# / 2025 Mar;19(3):785-807

Contributing Institute(s):
  1. B067 Juniorgruppe Brain Tumor Translational Target (B067)
  2. A160 Redoxregulation (A160)
  3. Proteomics (W120)
Research Program(s):
  1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2024
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2024-10-28, last modified 2025-03-10



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)